us > Maine > Oxford > Gilead > Latest & Local News
Gilead news
Biopharma bites: AstraZeneca's camizestrant under FDA's microscope, and more from Newron, Gilead, OSR - FirstWord Pharma
FirstWord Pharma
📢 Published on 📅 April 30, 2026 🕒 00:38
Insider Sell: Daniel O'Day Sells 10,000 Shares of Gilead Sciences Inc (GILD) - GuruFocus
Insider Sell: Daniel O'Day Sells 10,000 Shares of Gilead Sciences Inc (GILD)
GuruFocus
📢 Published on 📅 April 30, 2026 🕒 00:05
Gilead Sciences (NASDAQ:GILD) CEO Sells $1,291,600.00 in Stock - MarketBeat
Gilead Sciences (NASDAQ:GILD) CEO Sells $1,291,600.00 in Stock
MarketBeat
📢 Published on 📅 April 29, 2026 🕒 23:43
‘The Testaments’ Stars Ann Dowd and Mabel Li on Lydia and Vidala’s Dark Past, Gilead’s ‘Aunts’ Program Origin Story - Variety
Variety
📢 Published on 📅 April 29, 2026 🕒 23:30
Vanguard reports 93.3M-share, 7.51% stake in Gilead Sciences (NASDAQ: GILD) - Stock Titan
Vanguard reports 93.3M-share, 7.51% stake in Gilead Sciences (NASDAQ: GILD)
Stock Titan
📢 Published on 📅 April 29, 2026 🕒 22:41
Gilead Sciences CEO Daniel O’Day sells over $1.29m in stock - Investing.com
Gilead Sciences CEO Daniel O’Day sells over $1.29m in stock
Investing.com
📢 Published on 📅 April 29, 2026 🕒 22:23
Gilead (NASDAQ: GILD) CEO sells 10,000 shares in planned trade - Stock Titan
Gilead (NASDAQ: GILD) CEO sells 10,000 shares in planned trade
Stock Titan
📢 Published on 📅 April 29, 2026 🕒 21:53
The Testaments' [Spoiler] Is Secretly Working Against Gilead! Read Episode 6 Recap - IMDb
The Testaments' [Spoiler] Is Secretly Working Against Gilead! Read Episode 6 Recap
IMDb
📢 Published on 📅 April 29, 2026 🕒 20:20
The Testaments' [Spoiler] Is Secretly Working Against Gilead! Read Episode 6 Recap - TVLine
The Testaments' [Spoiler] Is Secretly Working Against Gilead! Read Episode 6 Recap
TVLine
📢 Published on 📅 April 29, 2026 🕒 19:42
Assessing Whether Gilead Sciences (GILD) Looks Undervalued After Recent Share Price Performance - simplywall.st
Assessing Whether Gilead Sciences (GILD) Looks Undervalued After Recent Share Price Performance
simplywall.st
📢 Published on 📅 April 29, 2026 🕒 19:13
Gilead Sciences Stock: Three Acquisitions, Four Launches, and a 20% Discount to Wall Street’s Target - TIKR.com
Gilead Sciences Stock: Three Acquisitions, Four Launches, and a 20% Discount to Wall Street’s Target
TIKR.com
📢 Published on 📅 April 29, 2026 🕒 18:16
A first look at ‘The Testaments’ - The Hofstra Chronicle
A first look at ‘The Testaments’
The Hofstra Chronicle
📢 Published on 📅 April 29, 2026 🕒 16:59
The Testaments Season 1 Episode 6 Is Gut Wrenching and Gratifying All At Once. - Scenes In Color
The Testaments Season 1 Episode 6 Is Gut Wrenching and Gratifying All At Once.
Scenes In Color
📢 Published on 📅 April 29, 2026 🕒 16:25
U.S. FDA Grants Priority Review of New Drug Application for Gilead’s Once-Daily HIV Treatment of Bictegravir Plus Lenacapavir - BioSpace
BioSpace
📢 Published on 📅 April 29, 2026 🕒 16:10
GILD: Gilead's New HIV Treatment Gains FDA Acceptance - GuruFocus
GILD: Gilead's New HIV Treatment Gains FDA Acceptance
GuruFocus
📢 Published on 📅 April 29, 2026 🕒 16:02
Kymera Therapeutics earnings on deck after Gilead deal milestone By Investing.com - Investing.com Nigeria
Kymera Therapeutics earnings on deck after Gilead deal milestone By Investing.com
Investing.com Nigeria
📢 Published on 📅 April 29, 2026 🕒 15:31
Morgan Stanley Forecasts Strong Price Appreciation for Gilead Sciences (NASDAQ:GILD) Stock - MarketBeat
Morgan Stanley Forecasts Strong Price Appreciation for Gilead Sciences (NASDAQ:GILD) Stock
MarketBeat
📢 Published on 📅 April 29, 2026 🕒 14:06
The Testaments Recap: A Woman’s Touch - Vulture
The Testaments Recap: A Woman’s Touch
Vulture
📢 Published on 📅 April 29, 2026 🕒 14:00
FDA Will Review Gilead’s HIV BIC/LEN Combination Treatment - Contagion Live
FDA Will Review Gilead’s HIV BIC/LEN Combination Treatment
Contagion Live
📢 Published on 📅 April 29, 2026 🕒 13:53
'The Testaments' Has an Aunt Lydia Problem - Time Magazine
'The Testaments' Has an Aunt Lydia Problem
Time Magazine
📢 Published on 📅 April 29, 2026 🕒 13:39
FDA accepts Gilead’s HIV treatment combination for review - Investing.com
FDA accepts Gilead’s HIV treatment combination for review
Investing.com
📢 Published on 📅 April 29, 2026 🕒 13:05
U.S. FDA Grants Priority Review of New Drug Application for Gilead’s Once-Daily HIV Treatment of Bictegravir Plus Lenacapavir - Business Wire
Business Wire
📢 Published on 📅 April 29, 2026 🕒 12:30
Wilson Sonsini Advises Arcellx on Merger with Gilead Sciences - Wilson Sonsini
Wilson Sonsini Advises Arcellx on Merger with Gilead Sciences
Wilson Sonsini
📢 Published on 📅 April 29, 2026 🕒 08:45
Gilead and Arcellx advance CAR T partnership in multiple myeloma - PharmiWeb.com
Gilead and Arcellx advance CAR T partnership in multiple myeloma
PharmiWeb.com
📢 Published on 📅 April 29, 2026 🕒 08:07
Bristol Myers, Medtronic, Gilead: Top Dividend Healthcare Stocks in April 2026 - News and Statistics - IndexBox
Bristol Myers, Medtronic, Gilead: Top Dividend Healthcare Stocks in April 2026 - News and Statistics
IndexBox
📢 Published on 📅 April 29, 2026 🕒 00:31
Andover man, 43, dead after shooting on Gilead Road, police say - CTPost
Andover man, 43, dead after shooting on Gilead Road, police say
CTPost
📢 Published on 📅 April 28, 2026 🕒 21:19
Arcellx (NASDAQ: ACLX) director cashes out in Gilead merger deal - Stock Titan
Arcellx (NASDAQ: ACLX) director cashes out in Gilead merger deal
Stock Titan
📢 Published on 📅 April 28, 2026 🕒 20:34
AIDS group sues Trump administration over undisclosed agreement with Gilead - statnews.com
AIDS group sues Trump administration over undisclosed agreement with Gilead
statnews.com
📢 Published on 📅 April 28, 2026 🕒 20:32
Arcellx (ACLX) director cancels stock options for cash and CVRs in Gilead merger - Stock Titan
Arcellx (ACLX) director cancels stock options for cash and CVRs in Gilead merger
Stock Titan
📢 Published on 📅 April 28, 2026 🕒 20:29
Arcellx (ACLX) director’s shares and options cashed out in Gilead deal - Stock Titan
Arcellx (ACLX) director’s shares and options cashed out in Gilead deal
Stock Titan
📢 Published on 📅 April 28, 2026 🕒 20:28
Arcellx (ACLX) CMO reshapes stock and options in Gilead deal - Stock Titan
Arcellx (ACLX) CMO reshapes stock and options in Gilead deal
Stock Titan
📢 Published on 📅 April 28, 2026 🕒 20:24
Arcellx (ACLX) equity cashed out at $115 plus CVRs in Gilead deal - Stock Titan
Arcellx (ACLX) equity cashed out at $115 plus CVRs in Gilead deal
Stock Titan
📢 Published on 📅 April 28, 2026 🕒 20:23
Gilead completes Arcellx merger; Arcellx (NASDAQ: ACLX) deregisters S-3 - Stock Titan
Gilead completes Arcellx merger; Arcellx (NASDAQ: ACLX) deregisters S-3
Stock Titan
📢 Published on 📅 April 28, 2026 🕒 20:17
Gilead buys Arcellx (ACLX) for $115 cash plus CVR; holder at 0% - Stock Titan
Gilead buys Arcellx (ACLX) for $115 cash plus CVR; holder at 0%
Stock Titan
📢 Published on 📅 April 28, 2026 🕒 20:15
Gilead buys Arcellx (NASDAQ: ACLX) in $7.1B cash and CVR deal - Stock Titan
Gilead buys Arcellx (NASDAQ: ACLX) in $7.1B cash and CVR deal
Stock Titan
📢 Published on 📅 April 28, 2026 🕒 20:05
Andover man, 43, dead after shooting on Gilead Road, police say - CT Insider
Andover man, 43, dead after shooting on Gilead Road, police say
CT Insider
📢 Published on 📅 April 28, 2026 🕒 19:52
With ‘lessons learned,’ Kite prepares to hit the ground running as next-gen CAR-T decision looms - Fierce Pharma
With ‘lessons learned,’ Kite prepares to hit the ground running as next-gen CAR-T decision looms
Fierce Pharma
📢 Published on 📅 April 28, 2026 🕒 15:30
Gilead Sciences Crosses Critical Breakout Level. The Stock Can Gain 35% From Here. - Barron's
Gilead Sciences Crosses Critical Breakout Level. The Stock Can Gain 35% From Here.
Barron's
📢 Published on 📅 April 28, 2026 🕒 15:21
Gilead Sciences completes acquisition of Arcellx ahead of potential commercial launch of Anito-cel - marketscreener.com
Gilead Sciences completes acquisition of Arcellx ahead of potential commercial launch of Anito-cel
marketscreener.com
📢 Published on 📅 April 28, 2026 🕒 15:12
Gilead Completes $7.8 Billion Acquisition of Arcellx - Contract Pharma
Gilead Completes $7.8 Billion Acquisition of Arcellx
Contract Pharma
📢 Published on 📅 April 28, 2026 🕒 15:04
Gilead Sciences (GILD) Completes Acquisition of Arcellx, Inc. - GuruFocus
Gilead Sciences (GILD) Completes Acquisition of Arcellx, Inc.
GuruFocus
📢 Published on 📅 April 28, 2026 🕒 14:42
Gilead Sciences Completes $7.8 Billion Acquisition of Arcellx, Securing Full Control of CAR T Therapy Anito-cel - citybiz
citybiz
📢 Published on 📅 April 28, 2026 🕒 13:54
Gilead Sciences Completes Acquisition of Arcellx and Anito-cel - TipRanks
Gilead Sciences Completes Acquisition of Arcellx and Anito-cel
TipRanks
📢 Published on 📅 April 28, 2026 🕒 13:33
Gilead fully acquires Arcellx (NASDAQ: ACLX) as tender offer and merger close - Stock Titan
Gilead fully acquires Arcellx (NASDAQ: ACLX) as tender offer and merger close
Stock Titan
📢 Published on 📅 April 28, 2026 🕒 13:13
Gilead completes $7.8 billion acquisition of Arcellx - Investing.com
Gilead completes $7.8 billion acquisition of Arcellx
Investing.com
📢 Published on 📅 April 28, 2026 🕒 13:02
Gilead Sciences reports new GTPase KRAS G12D inhibitors and degraders - BioWorld News
Gilead Sciences reports new GTPase KRAS G12D inhibitors and degraders
BioWorld News
📢 Published on 📅 April 28, 2026 🕒 13:00
Gilead (NASDAQ: GILD) closes Arcellx deal, gains full control of anito-cel - Stock Titan
Gilead (NASDAQ: GILD) closes Arcellx deal, gains full control of anito-cel
Stock Titan
📢 Published on 📅 April 28, 2026 🕒 12:56
Gilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-cel - Business Wire
Gilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-cel
Business Wire
📢 Published on 📅 April 28, 2026 🕒 12:45
Mitsubishi UFJ Trust & Banking Corp Decreases Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Mitsubishi UFJ Trust & Banking Corp Decreases Stake in Gilead Sciences, Inc. $GILD
MarketBeat
📢 Published on 📅 April 28, 2026 🕒 11:10
AHF’s Gilead Shareholder Resolution Seeks Transparency on Drug Patent Exclusivities - AIDS Healthcare Foundation
AHF’s Gilead Shareholder Resolution Seeks Transparency on Drug Patent Exclusivities
AIDS Healthcare Foundation
📢 Published on 📅 April 27, 2026 🕒 22:27
Gilead Sciences (GILD) Builds Defensive Moat With HIV Franchise Ahead of May 7 Earnings - AlphaStreet
Gilead Sciences (GILD) Builds Defensive Moat With HIV Franchise Ahead of May 7 Earnings
AlphaStreet
📢 Published on 📅 April 27, 2026 🕒 18:53
Gilead’s pipeline strategy in 2026: A broadening focus beyond HIV - Labiotech.eu
Gilead’s pipeline strategy in 2026: A broadening focus beyond HIV
Labiotech.eu
📢 Published on 📅 April 27, 2026 🕒 13:00
Pictet Asset Management Holding SA Sells 326,886 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Pictet Asset Management Holding SA Sells 326,886 Shares of Gilead Sciences, Inc. $GILD
MarketBeat
📢 Published on 📅 April 27, 2026 🕒 11:08
State of Michigan Retirement System Sells 10,800 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
State of Michigan Retirement System Sells 10,800 Shares of Gilead Sciences, Inc. $GILD
MarketBeat
📢 Published on 📅 April 27, 2026 🕒 10:52
Sanctuary Advisors LLC Has $27.19 Million Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Sanctuary Advisors LLC Has $27.19 Million Stock Position in Gilead Sciences, Inc. $GILD
MarketBeat
📢 Published on 📅 April 27, 2026 🕒 10:26
Assessing Arcus Biosciences (RCUS) Valuation After STAR-121 Termination And Gilead Option Changes - simplywall.st
Assessing Arcus Biosciences (RCUS) Valuation After STAR-121 Termination And Gilead Option Changes
simplywall.st
📢 Published on 📅 April 27, 2026 🕒 08:24
Gilead Sciences (GILD) Set to Acquire Arcellx - Yahoo Finance
Gilead Sciences (GILD) Set to Acquire Arcellx
Yahoo Finance
📢 Published on 📅 April 27, 2026 🕒 06:04
Person in Andover flown to hospital after suffering gunshot wound, police say - New Haven Register
Person in Andover flown to hospital after suffering gunshot wound, police say
New Haven Register
📢 Published on 📅 April 26, 2026 🕒 22:21
A Look At Kymera Therapeutics (KYMR) Valuation After Fast Track News And Gilead Collaboration Progress - Yahoo Finance
Yahoo Finance
📢 Published on 📅 April 26, 2026 🕒 22:05
Person in Andover flown to hospital after suffering gunshot wound, police say - CT Insider
Person in Andover flown to hospital after suffering gunshot wound, police say
CT Insider
📢 Published on 📅 April 26, 2026 🕒 22:04
Gilead Sciences Inc. (GILD): Growing Popularity as Defensive Stock - Yahoo Finance
Gilead Sciences Inc. (GILD): Growing Popularity as Defensive Stock
Yahoo Finance
📢 Published on 📅 April 26, 2026 🕒 20:02
Vanguard Group Inc. Grows Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Vanguard Group Inc. Grows Stock Holdings in Gilead Sciences, Inc. $GILD
MarketBeat
📢 Published on 📅 April 26, 2026 🕒 12:24
Concurrent Investment Advisors LLC Grows Position in Gilead Sciences, Inc. $GILD - MarketBeat
Concurrent Investment Advisors LLC Grows Position in Gilead Sciences, Inc. $GILD
MarketBeat
📢 Published on 📅 April 26, 2026 🕒 08:36
Axecap Investments LLC Has $3.43 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Axecap Investments LLC Has $3.43 Million Stock Holdings in Gilead Sciences, Inc. $GILD
MarketBeat
📢 Published on 📅 April 26, 2026 🕒 07:18
AEGON ASSET MANAGEMENT UK Plc Reduces Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
AEGON ASSET MANAGEMENT UK Plc Reduces Holdings in Gilead Sciences, Inc. $GILD
MarketBeat
📢 Published on 📅 April 26, 2026 🕒 07:12
Munich Reinsurance Co Stock Corp in Munich Boosts Position in Gilead Sciences, Inc. $GILD - MarketBeat
Munich Reinsurance Co Stock Corp in Munich Boosts Position in Gilead Sciences, Inc. $GILD
MarketBeat
📢 Published on 📅 April 25, 2026 🕒 12:54
Gilead Sciences, Inc. $GILD Shares Sold by Polaris Capital Management LLC - MarketBeat
Gilead Sciences, Inc. $GILD Shares Sold by Polaris Capital Management LLC
MarketBeat
📢 Published on 📅 April 25, 2026 🕒 12:50
Gilead Sciences Inc (NASDAQ:GILD): A Balanced Dividend Play with Strong Financial Health and Profitability - ChartMill
ChartMill
📢 Published on 📅 April 25, 2026 🕒 12:10
Calamos Advisors LLC Sells 9,121 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Calamos Advisors LLC Sells 9,121 Shares of Gilead Sciences, Inc. $GILD
MarketBeat
📢 Published on 📅 April 25, 2026 🕒 07:59
Dean's Speaker Series: Gilead CEO Daniel O’Day on why diverse perspectives drive progress - University of California, Berkeley
Dean's Speaker Series: Gilead CEO Daniel O’Day on why diverse perspectives drive progress
University of California, Berkeley
📢 Published on 📅 April 24, 2026 🕒 23:07
Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts
Yahoo Finance
📢 Published on 📅 April 24, 2026 🕒 21:50
Gilead’s Arcus Pullback and Idvynso HIV Challenge Might Change The Case For Investing In GILD - Yahoo Finance
Gilead’s Arcus Pullback and Idvynso HIV Challenge Might Change The Case For Investing In GILD
Yahoo Finance
📢 Published on 📅 April 24, 2026 🕒 20:06
Gilead Sciences Shows Rising Relative Strength; Still Shy Of Key Benchmark - Investor's Business Daily
Gilead Sciences Shows Rising Relative Strength; Still Shy Of Key Benchmark
Investor's Business Daily
📢 Published on 📅 April 24, 2026 🕒 07:00
Transforming What’s Next, Now: Gilead’s 2025 Responsible Business and Impact Report - Gilead Sciences
Transforming What’s Next, Now: Gilead’s 2025 Responsible Business and Impact Report
Gilead Sciences
📢 Published on 📅 April 24, 2026 🕒 01:14
Gilead loosens ties to Arcus after TIGIT dream finally ends in phase 3 failure - Fierce Biotech
Gilead loosens ties to Arcus after TIGIT dream finally ends in phase 3 failure
Fierce Biotech
📢 Published on 📅 April 21, 2026 🕒 07:07
Gilead, Arcus tumble again in TIGIT, triggering 2 trial culls - BioSpace
Gilead, Arcus tumble again in TIGIT, triggering 2 trial culls
BioSpace
📢 Published on 📅 April 21, 2026 🕒 07:00
Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer - Business Wire
Business Wire
📢 Published on 📅 April 17, 2026 🕒 07:00
Gilead is not doing enough to expand access to groundbreaking HIV prevention medicine - Doctors Without Borders
Gilead is not doing enough to expand access to groundbreaking HIV prevention medicine
Doctors Without Borders
📢 Published on 📅 April 14, 2026 🕒 07:00
Why this Gilead Sciences exec says managing energy, not time, drives performance - Fortune
Why this Gilead Sciences exec says managing energy, not time, drives performance
Fortune
📢 Published on 📅 April 13, 2026 🕒 07:00
Commentary: This pharma company makes a miracle HIV drug, but is blocking access for millions of low-income people - Los Angeles Times
Los Angeles Times
📢 Published on 📅 April 9, 2026 🕒 07:00
Gilead pays Kymera $45M to glue preclinical protein degrader onto burgeoning oncology pipeline - Fierce Biotech
Gilead pays Kymera $45M to glue preclinical protein degrader onto burgeoning oncology pipeline
Fierce Biotech
📢 Published on 📅 April 9, 2026 🕒 07:00
The Testaments: Plot, Release Date, Cast & How To Watch | Explore Disney+ - Disney Plus
The Testaments: Plot, Release Date, Cast & How To Watch | Explore Disney+
Disney Plus
📢 Published on 📅 April 8, 2026 🕒 07:00
Gilead's Commitment to Bridging the Unmet HIV Treatment Gap - Gilead Sciences
Gilead's Commitment to Bridging the Unmet HIV Treatment Gap
Gilead Sciences
📢 Published on 📅 April 8, 2026 🕒 07:00
With 3 quick buyouts, Gilead leans into its latest transformation - BioPharma Dive
With 3 quick buyouts, Gilead leans into its latest transformation
BioPharma Dive
📢 Published on 📅 April 8, 2026 🕒 07:00
With 3 acquisitions to digest, Gilead shifts focus from M&A to pipeline that has 'never been stronger' - Fierce Biotech
Fierce Biotech
📢 Published on 📅 April 8, 2026 🕒 07:00
Gilead pays $3.1B for Tubulis to bolster oncology ADC pipeline - Fierce Biotech
Gilead pays $3.1B for Tubulis to bolster oncology ADC pipeline
Fierce Biotech
📢 Published on 📅 April 7, 2026 🕒 07:00
Gilead continues M&A surge with $3.1B deal for ADC specialist Tubulis - BioPharma Dive
Gilead continues M&A surge with $3.1B deal for ADC specialist Tubulis
BioPharma Dive
📢 Published on 📅 April 7, 2026 🕒 07:00
‘The Testaments’ series follows a new generation of girls growing up in Gilead - Reuters
‘The Testaments’ series follows a new generation of girls growing up in Gilead
Reuters
📢 Published on 📅 April 7, 2026 🕒 07:00
Gilead to buy cancer biotech Tubulis for more than $3 billion - statnews.com
Gilead to buy cancer biotech Tubulis for more than $3 billion
statnews.com
📢 Published on 📅 April 7, 2026 🕒 07:00
Gilead to Buy German Biotech Tubulis for $3 Billion for Experimental Cancer Drugs - WSJ
Gilead to Buy German Biotech Tubulis for $3 Billion for Experimental Cancer Drugs
WSJ
📢 Published on 📅 April 7, 2026 🕒 07:00
Gilead to buy Germany's Tubulis for up to $5 billion to boost cancer pipeline - Reuters
Gilead to buy Germany's Tubulis for up to $5 billion to boost cancer pipeline
Reuters
📢 Published on 📅 April 7, 2026 🕒 07:00
Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline - Business Wire
Business Wire
📢 Published on 📅 April 7, 2026 🕒 07:00
Gilead Swallows Another Partner, Paying up to $5B for ADC Specialist Tubulis - BioSpace
Gilead Swallows Another Partner, Paying up to $5B for ADC Specialist Tubulis
BioSpace
📢 Published on 📅 April 7, 2026 🕒 07:00
Biopharma bites: Job cuts at Gilead, and Denali-Takeda deal demise - FirstWord Pharma
Biopharma bites: Job cuts at Gilead, and Denali-Takeda deal demise
FirstWord Pharma
📢 Published on 📅 April 3, 2026 🕒 17:11
Fierce Biotech: Gilead cancels midstage HIV trial as FDA’s clinical hold remains intact - European AIDS Treatment Group
Fierce Biotech: Gilead cancels midstage HIV trial as FDA’s clinical hold remains intact
European AIDS Treatment Group
📢 Published on 📅 April 3, 2026 🕒 07:00
Hulu’s “The Testaments” Returns to Gilead For Another Timely Tale About Privilege and Complicity - Roger Ebert
Hulu’s “The Testaments” Returns to Gilead For Another Timely Tale About Privilege and Complicity
Roger Ebert
📢 Published on 📅 April 2, 2026 🕒 07:00
Gilead cancels midstage HIV trial as FDA’s clinical hold remains intact - Fierce Biotech
Gilead cancels midstage HIV trial as FDA’s clinical hold remains intact
Fierce Biotech
📢 Published on 📅 April 1, 2026 🕒 07:00
[Press release] Médecins Sans Frontières: Gilead refuses to sell groundbreaking HIV prevention drug to MSF - European AIDS Treatment Group
European AIDS Treatment Group
📢 Published on 📅 March 30, 2026 🕒 22:55
Gilead refuses to sell groundbreaking HIV prevention drug to MSF - Doctors Without Borders
Gilead refuses to sell groundbreaking HIV prevention drug to MSF
Doctors Without Borders
📢 Published on 📅 March 30, 2026 🕒 13:47
Open letter to Gilead: Prevention should not be a privilege - Doctors Without Borders
Open letter to Gilead: Prevention should not be a privilege
Doctors Without Borders
📢 Published on 📅 March 30, 2026 🕒 07:00
Latest news from Gilead related to "United States" | Latest News from the United States, United Kingdom & India, local, breaking news
Welcome to news.free-list.org, your online destination for the latest news and breaking stories from the United States, the United Kingdom, and India. Stay informed with real-time updates gathered from trusted sources, newspapers, and online news websites worldwide.
Explore a wide range of news categories including politics, business, technology, health, education, entertainment, and sports. Our platform uses RSS feeds to continuously deliver fresh and up-to-date content, helping you follow global events as they happen.
Whether you are looking for US news, UK headlines, or the latest developments in India, you can easily browse and discover trending topics and important stories in one place. The content is automatically updated to reflect current events and breaking news.
news.free-list.org acts as a modern news aggregator, offering a streamlined way to access news articles from multiple sources without having to visit each site individually. Stay connected to what matters most with fast, reliable, and organized news coverage.
Discover top stories, trending news, and global updates every day. Follow the latest headlines and stay informed about major events across the United States, the United Kingdom, and India with ease.

